
CBD-MediHaze
Feminised, Indoor & Outdoor
Reference: 7012-5
Manufacturer: CBD-Crew
CBD Medihaze – Sativa-dominant, CBD-rich plant for medicinal applications
CBD Medihaze is a sativa-dominant, high-CBD strain that is one of the latest releases from CBD Crew in 2013. This strain is the result of crossing Super Silver Haze with the classic Nevil Haze, and then with CBD-rich parent plants for a higher CBD content.
1 Item Warning: Last items in stock!
Data sheet
Sex | Feminised |
Variety | Mostly Sativa (min 70%) |
Flowering Type | Photoperiod |
THC Content | High (11% - 19%) |
CBD Content | High (11% - 19%) |
Growing Location | Indoor & Outdoor |
Yield Indoor (g/m²) | High (401 - 500g/m²) |
Yield Outdoor (g/plant) | High (200 - 500g) |
Flowering Time Indoor | 09 weeks |
Harvest Month Outdoor | October |
Genetics | Super Silver Haze x Neville's Haze x CBD-plant |
More info
This hybrid parentage offers a wide range of THC/CBD ratios, making it highly promising for the medical community.
Genetics & origin
- Genetics: 20% indica / 80% sativa
- Flowering time: 9-10 weeks
- Yield (under a 600W lamp): 450-550 g/m²
- THC %: 6-15 %
- CBD %: 6-15 %
- THC:CBD ratio: 1:1 to 1:10 – the ratio varies, making this plant particularly versatile for different medical applications.
Flavour & aroma
- Aroma: A rich, honey-sweet scent with a strong spiciness and hints of lemon, making the flavours complex and enjoyable. A very pleasant experience, especially when cured for 6 weeks after harvest.
Growth & flowering time
- Flowering time: 9-10 weeks (12/12 light cycle)
- Yield: 450-550 g/m²
- Height and Growth: This plant does not stretch excessively when properly cared for, making it a suitable choice for growers with limited space.
Growing Recommendations
- Difficulty Level: Medium
- Best for: growers looking for a sativa-dominant strain that produces stable yields without growing too tall. It is well suited to indoor gardens and can be harvested outdoors in late autumn (mid-October).
Medical uses
- THC:CBD ratio: 1:1 to 1:10 – This wide variability in THC and CBD makes CBD Medihaze an excellent choice for patients who require a mix of CBD and THC. It can be used to treat chronic pain, inflammation, anxiety, sleep disorders and other medical conditions. The effect is not overwhelmingly psychoactive, offering a mild, soothing effect.
Conclusion CBD Medihaze is a promising plant for medical users seeking both the benefits of CBD and the gentle effects of THC. Its sativa-dominant nature makes it an excellent choice for therapeutic use without being too psychoactive. With a pleasant aroma and a balanced THC:CBD ratio, it is a great choice for those seeking a high concentration of CBD for their medical use.